# Baclofen in Preventing Postoperative Nausea and Vomiting After Bariatric Surgery

> **NCT05516953** · PHASE2,PHASE3 · COMPLETED · sponsor: **Tanta University** · enrollment: 100 (actual)

## Conditions studied

- Postoperative Nausea and Vomiting
- Laparoscopic Sleeve Gastrectomy
- Morbid Obesity

## Interventions

- **DRUG:** Baclofen Tablets

## Key facts

- **NCT ID:** NCT05516953
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-22
- **Primary completion:** 2024-12-28
- **Final completion:** 2025-02-28
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05516953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05516953, "Baclofen in Preventing Postoperative Nausea and Vomiting After Bariatric Surgery". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05516953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*